COBRA VENTURE CORP (CBV.CA) Fundamental Analysis & Valuation

TSX-V:CBV • CA19104W1041

Current stock price

0.14 CAD
+0.02 (+12%)
Last:

This CBV.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CBV.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CBV has reported negative net income.
  • In the past year CBV had a positive cash flow from operations.
  • In multiple years CBV reported negative net income over the last 5 years.
  • Each year in the past 5 years CBV had a positive operating cash flow.
CBV.CA Yearly Net Income VS EBIT VS OCF VS FCFCBV.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500K -500K

1.2 Ratios

  • Looking at the Return On Assets, with a value of -4.13%, CBV is in line with its industry, outperforming 44.65% of the companies in the same industry.
  • With a Return On Equity value of -4.32%, CBV perfoms like the industry average, outperforming 47.44% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 0.20%, CBV is in line with its industry, outperforming 46.51% of the companies in the same industry.
Industry RankSector Rank
ROA -4.13%
ROE -4.32%
ROIC 0.2%
ROA(3y)1.76%
ROA(5y)0.44%
ROE(3y)1.88%
ROE(5y)0.47%
ROIC(3y)N/A
ROIC(5y)N/A
CBV.CA Yearly ROA, ROE, ROICCBV.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • Looking at the Operating Margin, with a value of 0.59%, CBV is in line with its industry, outperforming 46.05% of the companies in the same industry.
  • CBV has a Gross Margin of 44.78%. This is in the better half of the industry: CBV outperforms 69.77% of its industry peers.
  • CBV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.59%
PM (TTM) N/A
GM 44.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.24%
GM growth 5Y1.39%
CBV.CA Yearly Profit, Operating, Gross MarginsCBV.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. CBV.CA Health Analysis

2.1 Basic Checks

  • CBV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, CBV has about the same amount of shares outstanding.
  • The number of shares outstanding for CBV has been increased compared to 5 years ago.
  • CBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CBV.CA Yearly Shares OutstandingCBV.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CBV.CA Yearly Total Debt VS Total AssetsCBV.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

  • An Altman-Z score of 11.78 indicates that CBV is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 11.78, CBV belongs to the best of the industry, outperforming 92.09% of the companies in the same industry.
  • CBV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.78
ROIC/WACC0.02
WACC8.12%
CBV.CA Yearly LT Debt VS Equity VS FCFCBV.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M 2M 3M

2.3 Liquidity

  • CBV has a Current Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 42.65, CBV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • CBV has a Quick Ratio of 42.65. This indicates that CBV is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CBV (42.65) is better than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 42.65
Quick Ratio 42.65
CBV.CA Yearly Current Assets VS Current LiabilitesCBV.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CBV.CA Growth Analysis

3.1 Past

  • CBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -360.71%.
  • CBV shows a decrease in Revenue. In the last year, the revenue decreased by -1.88%.
  • The Revenue has been decreasing by -1.48% on average over the past years.
EPS 1Y (TTM)-360.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
Revenue 1Y (TTM)-1.88%
Revenue growth 3Y-6.83%
Revenue growth 5Y-1.48%
Sales Q2Q%27.43%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBV.CA Yearly Revenue VS EstimatesCBV.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

Find the best growth stocksShow best growing peers

1

4. CBV.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • CBV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBV.CA Price Earnings VS Forward Price EarningsCBV.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 98.60% of the companies in the same industry are more expensive than CBV, based on the Enterprise Value to EBITDA ratio.
  • CBV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 189.92
EV/EBITDA 0.4
CBV.CA Per share dataCBV.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CBV.CA Dividend Analysis

5.1 Amount

  • No dividends for CBV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CBV.CA Fundamentals: All Metrics, Ratios and Statistics

COBRA VENTURE CORP

TSX-V:CBV (7/8/2025, 7:00:00 PM)

0.14

+0.02 (+12%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners45.08%
Ins Owner ChangeN/A
Market Cap2.32M
Revenue(TTM)1.36M
Net Income(TTM)-121.70K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.03
Dividend Growth(5Y)N/A
DP-367.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.7
P/FCF 189.92
P/OCF 62.62
P/B 0.82
P/tB 0.82
EV/EBITDA 0.4
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.53%
OCF(TTM)0
OCFY1.6%
SpS0.08
BVpS0.17
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -4.13%
ROE -4.32%
ROCE 0.28%
ROIC 0.2%
ROICexc 0.88%
ROICexgc 0.88%
OM 0.59%
PM (TTM) N/A
GM 44.78%
FCFM 0.9%
ROA(3y)1.76%
ROA(5y)0.44%
ROE(3y)1.88%
ROE(5y)0.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.24%
GM growth 5Y1.39%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 14.06%
Cap/Sales 1.82%
Interest Coverage 250
Cash Conversion 20.14%
Profit Quality N/A
Current Ratio 42.65
Quick Ratio 42.65
Altman-Z 11.78
F-Score5
WACC8.12%
ROIC/WACC0.02
Cap/Depr(3y)38.23%
Cap/Depr(5y)38.53%
Cap/Sales(3y)5.25%
Cap/Sales(5y)6.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-360.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.88%
Revenue growth 3Y-6.83%
Revenue growth 5Y-1.48%
Sales Q2Q%27.43%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-97.4%
FCF growth 3Y-39.04%
FCF growth 5YN/A
OCF growth 1Y-94.22%
OCF growth 3Y-35.4%
OCF growth 5Y-10.28%

COBRA VENTURE CORP / CBV.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for COBRA VENTURE CORP?

ChartMill assigns a fundamental rating of 4 / 10 to CBV.CA.


Can you provide the valuation status for COBRA VENTURE CORP?

ChartMill assigns a valuation rating of 1 / 10 to COBRA VENTURE CORP (CBV.CA). This can be considered as Overvalued.


Can you provide the profitability details for COBRA VENTURE CORP?

COBRA VENTURE CORP (CBV.CA) has a profitability rating of 3 / 10.


What is the financial health of COBRA VENTURE CORP (CBV.CA) stock?

The financial health rating of COBRA VENTURE CORP (CBV.CA) is 9 / 10.